Alembic Pharmaceuticals has secured final USFDA approval for its generic version of Doxorubicin Hydrochloride Liposome, a ...

No one wants to be diagnosed with or go through the physical and psychological toll of cancer. Which is why, sometimes, it's ...

Nanostics has secured funding from Genome Canada and Genome Alberta to expedite the ClarityDX Prostate test integration into ...

Cancer is costly for patients and the NHS—but it also has a significant impact on the U.K. economy, according to research led ...

Cancer in Uganda is arguably one of the scariest diseases to think about, later alone suffer from or deal with a patient ...

Around 135,000 women across New Zealand who are eligible but not currently enrolled for breast cancer screening will benefit from the successful ...

Shares of Alembic Pharmaceuticals climbed over 12% after the company secured USFDA approval for its generic Doxorubicin ...

In this blog, Gini Melesi, Head of Transformation, East of England Cancer Alliance, & Diane Whitney, Head of Brachytherapy Physics, Cambridge University Hospitals NHS Foundation Trust, explore the ...

Bengaluru: Scientists from Indian Institute of Science (IISc) have developed a simple, glowing paper sensor that could help ...

Kyle MacLachlan credits wife Desiree Gruber for inspiring his work with God’s Love We Deliver, a charity aiding those with ...

Mumbai: Shares of Alembic Pharmaceuticals surged 13.61 percent on Monday after a major regulatory approval. The stock hit a ...

USFDA approves Alembic Pharmaceuticals' generic Doxorubicin Hydrochloride Liposome injection for various cancers, equivalent ...